Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study
Yishai Ofran(Shaare Zedek Medical Center), Chezi Ganzel(Shaare Zedek Medical Center), Tsila Zuckerman(Johannes Gutenberg University Mainz), Netanel A. Horowitz(Rambam Health Care Campus), Shimrit Ringelstein(Technion – Israel Institute of Technology), Sharon Gino‐Moor(Bnai Zion Medical Center), Ariela Arad(Laniado Hospital), Ron Ram(Tel Aviv University), Ariella Tvito(Shaare Zedek Medical Center), Ilana Hellmann(Meir Medical Center), Ronit Leiba(Rambam Health Care Campus), Revital Saban(Shaare Zedek Medical Center), Jacob M. Rowe(Technion – Israel Institute of Technology), Michal Hayun(Rambam Health Care Campus), Shlomo Bulvik(Laniado Hospital), Israel Henig(Rush University Medical Center), Avraham Frisch(Rambam Health Care Campus), Moshe E. Gatt(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Ron Hoffman, Noa Lavi(Rambam Health Care Campus)
Cited by 1
Related Papers
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859